19 June 2013
Keywords: orion/abbott, expand, levosimendan, accord, finnish, drug, research
Article | 26 April 2004
Finnish drug research and wholesaling group Orion and US health care major Abbott Laboratories have expanded their licensing agreement for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 April 2004
18 June 2013
© 2013 thepharmaletter.com